This is the logo of the provider
EASL 2026 27 - 30 May 2026

Efficacy and safety of semaglutide 2.4 mg in the Japanese subgroup of the ESSENCE study

Authors :

Atsushi Nakajima1,2; Takeshi Okanoue3; Yoichi Hiasa4; Hirokazu Takahashi5; Adel Belloum6*; Nobuyoshi Kosaka7; Tomoyuki Nishida7; Arun J. Sanyal8

Affiliations
View Details Hide Details
Download .PDF
Keywords
MASH
Congress poster
GLP-1 RA
Semaglutide
PHASE 3 (RCT)